Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes

Clinical trial NCT07047183 · RECRUITING

Trial details

NCT number: NCT07047183
Sponsor: Yehui Tan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Neoplasms Transplantation

Start date: 2025-07-01
Primary completion: 2029-06-30
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.